Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhAngiostatin with Paclitaxel and Carboplatin in Advanced NSCLC
NCT00049790Phase 2Completed
- Sponsor
- CASI Pharmaceuticals, Inc.
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human angiostatin in non-small cell lung cancer (NSCLC), sponsored by CASI Pharmaceuticals, Inc.. Status: completed.
02
Drugs
recombinant human angiostatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00049790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049790.